{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-054274","form_type":"8-K","ticker":"NUTX","cik":"0001479681","company_name":"Nutex Health Inc.","filed_at":"2026-08-06T20:04:00+00:00","discovered_at":"2026-08-06T20:05:01.339228+00:00","generated_at":"2026-08-06T20:05:18.721132+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Nutex Health Q2 net income $65.8M vs loss $17.7M YoY; revenue down 13.6%","bullets":["Diluted EPS $9.38 vs $(2.95) in Q2 2025; six-month net income $112.6M, EPS $15.87.","Revenue $210.8M (-13.6% YoY) due to prior-year IDR benefits; hospital visits +9.6%.","Adjusted EBITDA $90.0M vs $71.6M; operating cash flow $34.2M vs $27.3M.","HaloMD amendment and CMS fee cut reduced contract services by $52.3M; expects 25-30% ongoing savings.","Cash $205.2M, long-term debt $31.1M; three new hospitals expected to open in H2 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-054274","json":"https://secwatch.observer/filing/0001628280-26-054274.json","markdown":"https://secwatch.observer/filing/0001628280-26-054274.md","text":"https://secwatch.observer/filing/0001628280-26-054274.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479681/000162828026054274/0001628280-26-054274-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479681/000162828026054274/nutx-20260806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T20:05:18.721132+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}